#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anaplastic thyroid cancer Factor IX deficiency Sjogren's syndrome Alagille syndrome Prodromal Alzheimer's disease Granulomatosis with polyangiitis Homocystinuria Dermatitis Soft tissue necrosis Osteochondrodysplasia Erythema Hereditary neuropathic amyloidosis Follicular lymphoma stage I Atypical haemolytic uraemic syndrome Glioblastoma multiforme More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Basic Information Lymphatic malformation – Treatment Usher’s syndrome – Treatment Pulmonary fibrosis – Trials in Disease Alveolar rhabdomyosarcoma – Diagnostics Haemophilia A without inhibitors – Trials in Disease Factor VIII deficiency – Basic Information Familial haemophagocytic lymphohistiocytosis – Life with Disease Rhabdomyosarcoma – Trials in Disease Ewing’s sarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sapropterin Dihydrochloride Alemtuzumab Mb-Cart20.1 Daxdilimab Amoxicillin Sodium Gabapentin Gs-1427 OBI-821 Xenon (129Xe) Valproate Semisodium Glutathione Danazol RNK001 Proline Lanreotide Gen1047 Ipn01194 Carcik-Cd19 Cells ANGIOTENSIN II Nitrous Oxide More therapies…

    Learn about Your Condition

    Tissue anoxia Pain in extremity Penile squamous cell carcinoma Carotid arteriosclerosis Acquired ATTR amyloidosis Testicular germ cell cancer Gastrectomy Endometrial cancer stage I Oral lichen planus Bone metabolism disorder Normal pressure hydrocephalus Neuropathic arthropathy Nasopharyngeal cancer Axial spondyloarthritis Factor IX deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Effectiveness of Lidocaine Hydrochloride and Sodium Chloride for Treating Headaches in Patients with Spontaneous Brain Bleeding

    Recruiting

    2 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Lidocaine Hydrochloride
    • Sodium Chloride
    Spain

  • Study on the Effects and Safety of Rituximab and Sodium Chloride in Patients with Active Systemic Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Sodium Chloride
    • Rituximab
    The Netherlands

  • Study on Rilzabrutinib for Patients Aged 10-65 with Sickle Cell Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Rilzabrutinib
    Belgium France Germany Greece Italy The Netherlands +1

  • Study on the Safety and Effects of MK-3120 for Patients with Advanced Solid Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • SKB410
    France The Netherlands Poland Spain

  • Study on Isoflurane, Propofol, and Dobutamine Hydrochloride for Sedation in Adults with Severe Cardiogenic Shock on ECMO

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiogenic shock
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Isoflurane
    • Propofol
    France

  • Study on Adding Darolutamide to First-Line Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer Using a Drug Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Cabazitaxel
    • Lutetium (177Lu) Oxodotreotide
    • Darolutamide
    Spain
Previous Page
1 … 208 209 210 211 212 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!